Carvedilol and Nephritis - interstitial - a phase IV clinical study of FDA data

Summary:

Nephritis - interstitial is reported as a side effect among people who take Carvedilol (carvedilol), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Nexium, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Nephritis - interstitial when taking Carvedilol. It is created by eHealthMe based on reports of 110,224 people who have side effects when taking Carvedilol from the FDA, and is updated regularly.

What is Carvedilol?

Carvedilol has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 112,649 Carvedilol users. Check the latest studies of Carvedilol.

What is Nephritis - interstitial?

Nephritis - interstitial (a kidney condition characterized by swelling in between the kidney tubules) is found to be associated with 1,494 drugs and 1,568 conditions by eHealthMe. Check the latest studies of Nephritis - interstitial.

On May, 11, 2026

110,224 people reported to have side effects when taking Carvedilol.
Among them, 491 people (0.45%) have Nephritis - interstitial.

Could Carvedilol cause Nephritis - interstitial?

Among these 491 people:

How long have people been on Carvedilol when they have Nephritis - interstitial? *

Click here to view more results

What is the gender of people who have Nephritis - interstitial when taking Carvedilol? *

Click here to view

What is the age of people who have Nephritis - interstitial when taking Carvedilol? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Carvedilol and have Nephritis - interstitial?

- Check whether Nephritis - interstitial is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Carvedilol:

Carvedilol (112,649 reports)

Nephritis - interstitial treatments and more:

Nephritis - interstitial (21,763 reports)

How severe was Nephritis - interstitial and when was it recovered:

Nephritis - interstitial in Carvedilol

Expand to all the drugs that have ingredients of carvedilol:

Nephritis - interstitial and drugs with ingredients of carvedilol (583 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Carvedilol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nephritis - interstitial:

Nephritis - interstitial (1,494 drugs)

Browse all the conditions that are associated with Nephritis - interstitial:

Nephritis - interstitial (1,568 conditions)

Related publications that referenced our studies

Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .
Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on carvedilol (the active ingredients of Carvedilol) and Carvedilol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.